Library search

Global M&A activity increasingly focuses on businesses with assets and/or sales in the BRIC countries - Brazil, Russia, India and China. From the end of May 2012, when the regime...Read more

As recently as a decade ago, there was a clear line separating R&D-based pharmaceutical companies and generic companies; on one side were innovator pharmaceutical companies focused on developing innovative new...Read more